OMER News and Press, Omeros Corporation From 04/18/23

2023-04-18 08:45:06 ET Palm Beach, FL – April 18, 2023 – FinancialNewsMedia.com News Commentary – Alcohol consumption and drug abuse have become public health concerns worldwide. Governments are working on ways to detect any symptoms of alcohol consumpt...

2023-04-10 10:13:43 ET –Omeros ( NASDAQ: OMER ) said it had been granted $6.69M from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, to develop its lead proprietary PDE7 inhibitor, OMS527, to treat cocaine use disorder. The grant ...

– Directs Company to Advance its Lead Proprietary PDE7 Inhibitor to Treat Cocaine Use Disorder – Omeros Corporation (Nasdaq: OMER) today announced that it has been awarded a grant from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Heal...

2023-03-27 08:19:05 ET Summary Omeros Corp's Q4 2022 earnings show a cash runway extending into 2025 and anticipation of Phase 3 trial readout of Narsoplimab in IgAN during 3Q23. The ARTEMIS Phase 3 trial in IgAN remains on track, and positive trial data could make Narsoplimab the...

2023-03-13 23:17:04 ET Omeros Corporation (OMER) Q4 2022 Earnings Conference Call March 13, 2023, 4:30 PM ET Company Participants Jennifer Williams - Investor Relations Dr. Greg Demopulos - Chairman and CEO Mike Jacobsen - Chief Accounting Officer Cathy Melfi...

2023-03-13 16:11:51 ET Omeros press release ( NASDAQ: OMER ): Q4 GAAP EPS of -$0.73 misses by $0.16 . At December 31, 2022, we had $194.9 million of cash, cash equivalents and short-term investments. In addition, we had $213.2 million of accounts receivable, substantia...

– Conference Call Today at 4:30 p.m. ET – Omeros Corporation (Nasdaq: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immuno...

2023-03-12 18:35:00 ET Omeros ( NASDAQ: OMER ) is scheduled to announce Q4 earnings results on Monday, March 13th, after market close. The consensus EPS Estimate is -$0.59 (-59.5% Y/Y) and the consensus Revenue Estimate is $0M Over the last 1 year, OMER has beaten EP...

2023-03-12 17:35:16 ET Major earnings expected after the bell on Monday include: WestPort Fuel Systems ( WPRT ) T2 Biosystems ( TTOO ) Omeros corporation ( OMER ) Turtle beach corporation ( HEAR ) Avid Bioservices ( CDMO ) For further details ...

Omeros Corporation (Nasdaq: OMER), in response to investor inquiries, is confirming that it has no banking or other financial relationship with Silicon Valley Bank. Omeros previously maintained a line of credit with Silicon Valley Bank, which the company allowed to expire in August 2022. Omer...